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AbsTrACT
Aims To compare macular structure and vasculature 
between neuromyelitis optica spectrum disorder 
(NMOSD) and primary open angle glaucoma (POAG) 
using optical coherence tomography angiography.
Methods NMOSD patients (n=124) with/without a 
history of optic neuritis (ON) (NMO+ON: 113 eyes; NMO- 
ON: 95 eyes), glaucomatous patients (n=102) with early/
advanced glaucoma (G- E: 74 eyes; G- A: 50 eyes) and 
healthy controls (n=62; 90 eyes) were imaged. The main 
outcome measures were macular ganglion cell- inner 
plexiform layer (GC- IPL) thickness, vessel density (VD) 
and perfusion density (PD) in the superficial capillary 
plexus, and diagnostic capabilities of the parameters as 
calculated by area under the curve (AUC).
results Significant losses in GC- IPL, VD and PD were 
detected in both patients with NMOSD and POAG. 
With matched losses in the peripapillary retinal nerve 
fibre layer, NMOSD group showed significant thinning 
of GC- IPL in the nasal- superior quadrant, whereas in 
POAG group, significant thinning was observed in the 
inferior and temporal- inferior quadrants. GC- IPL thinning 
was more prominent in the superior, nasal- superior and 
nasal- inferior quadrants in NMO+ON eyes. In G- A eyes, 
significant GC- IPL thinning was seen in the temporal- 
inferior quadrant. The specific structural parameters 
combining VD and foveal avascular zone (FAZ) indices 
showed the best diagnostic accuracies. The FAZ area in 
eyes with NMOSD was significantly smaller than the eyes 
of healthy controls and POAG.
Conclusion NMOSD and POAG have specific patterns 
of macular structural and vascular changes associated 
with pathophysiology. Our results indicate that FAZ could 
be a sensitive biomarker of macular changes in NMOSD.
InTroduCTIon
Neuromyelitis optica spectrum disorder (NMOSD) 
is an autoimmune inflammatory disease of the 
central nervous system with a prevalence of 0.5–4.4 
cases per 100000 people, which is characterised 
by severe attacks of recurrent optic neuritis (ON) 
and longitudinally extensive transverse myelitis.1 2 
NMOSD carries a poor visual prognosis and patients 
often suffer from recurrent episodes of ON, the 
severity of which is strongly correlated with the 
amount of retinal atrophy caused by cumulative 
ON episodes.3 4 The most common retinal abnor-
malities on optical coherence tomography (OCT) 
assessment of NMOSD are thinning of the peri-
papillary retinal nerve fibre layer (pRNFL) and the 
macular ganglion cell- inner plexiform layer (GC- 
IPL).5–7 Glaucoma affects more than 70 million 
people worldwide, with more than 80% of cases 
being primary open- angle glaucoma (POAG). This 
progressive optic neuropathy is also characterised 
by degeneration of the pRNFL and GC- IPL on 
OCT imaging.8 9
Several studies have investigated the patterns 
of retinal ganglion cell loss in NMOSD or POAG 
compared with healthy controls.3 10–12 The pRNFL 
in NMOSD was found to be particularly thin in the 
inferior and superior quadrants, as evaluated by four 
studies independently,10 and a similar pattern has been 
observed in POAG.8 In addition, an increased cup- disc 
ratio (C/D), which is one of the distinguishing charac-
teristics of POAG, has also been reported in patients 
with NMOSD.12 13 While the pRNFL comprises 
axons originating from ganglion cell neurons and 
reveals optic nerve status, macular GC- IPL is a 
direct reflection of the intrinsic ganglion cell bodies, 
which can provide information about primary retinal 
pathology.3 Macular GC- IPL measurements are 
more specific for detecting axonal loss than pRNFL 
measurements because macular parameters are not 
affected by optic nerve head oedema and are directly 
associated with visual outcomes.14 15 Currently, it 
is unclear whether the topographic changes in the 
macular GC- IPL and microvasculature are the same 
in NMOSD and POAG eyes.
Optical coherence tomography angiography 
(OCTA) techniques that non- invasively provide 
quantitative information on optic nerve struc-
ture and retinal vascular flow are likely to prove 
useful for specialists dealing with NMOSD and 
POAG, with the advantages of short acquisition 
times and sensitive measurements.16 17 In this 
study, we used OCTA to define specific damage 
patterns in the macular GC- IPL and microvascu-
lature, and to compare the patterns in NMOSD 
with those in POAG. The diagnostic accuracies 
for each group and subgroup (NMOSD with or 
without ON: NMO+ON, NMO- ON; glaucoma, 
early or advanced: G- E, G- A) were compared using 
different OCTA parameters.
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MATerIAls And MeThods
subject recruitment
Participants were volunteers recruited from Zhongshan 
Ophthalmic Center and Department of Neurology of Third 
Affiliated Hospital, Sun Yat- sen University, Guangzhou, China. 
Written informed consent was obtained from all participants. 
Exclusion criteria for all patients and the healthy controls 
included the following: (1) subjects diagnosed with other 
systemic diseases; (2) high myopia or hyperopia (spherical equiv-
alent refractive error greater than −6 diopters or +3 diopters); 
(3) significant media opacity; (4) age <18 years old; and (5) no 
definite diagnosis of NMOSD or POAG.
Two neurologists confirmed the NMOSD diagnosis according 
to the 2015 revised diagnostic criteria.18 Patients with an episode 
of ON within the last 6 months were excluded to minimise 
the effect of optic disc swelling. Patients with previous ocular 
surgeries or POAG were also excluded.
Two glaucoma subspecialty trained ophthalmologists inde-
pendently determined the presence of G- E and G- A. The POAG 
inclusion criteria were open angles on gonioscopy, with glauco-
matous features of optic nerve neuropathy and/or reliable and 
repeatable visual field defects. G- E was defined as POAG eyes 
with reliable and repeatable glaucomatous visual field damage 
(mean deviation ≥−6 dB). G- A was defined as POAG eyes with 
reliable and repeatable glaucomatous visual field damage (mean 
deviation <−6 dB).
The criteria for inclusion in the healthy control group were 
no family history of NMOSD or POAG, intraocular pressure 
<21 mmHg with no history of elevated intraocular pressure, 
normal- appearing optic disc, intact neuroretinal rim and pRNFL 
and normal visual fields.
examinations
All participants underwent an extensive ophthalmologic exam-
ination, including best- corrected visual acuity (BCVA), slit- lamp 
biomicroscopy, gonioscopy, intraocular pressure measurement 
with Goldmann applanation tonometry, dilated fundus exam-
ination, simultaneous stereo- photography of the optic disc, 
visual field testing by standard automated perimetry (SAP, 
Humphrey Field Analyser; 30-2 Swedish interactive threshold 
algorithm; Carl Zeiss Meditec, Jena, Germany) and OCTA 
scans (Cirrus 5000, V.10.0; Zeiss Meditec, California, USA). 
All patients with NMOSD were tested with MRI examinations 
and AQP4- IgG using commercially available cell- based assays 
(EUROIMMUN).19
oCTA acquisition and processing
OCTA imaging was performed using the high- definition OCT 
and AngioPlex device (Cirrus 5000, V.10.0; Zeiss Meditec, Cali-
fornia, USA) with a wavelength of 840 nm and an A- scan rate 
of 68000 scans per second. To minimise patient- related motion, 
participants in this study were instructed to focus their gaze 
on the centre of the cross target and remain as still as possible 
during acquisition of the OCTA scans. Minimal blinking was 
permitted only after each scan to keep the cornea lubricated, 
and moderate amount of artificial tears were used in cases when 
the participants’ eyes showed signs of drying out.
An optic disc cube 200×200 scan protocol was used for 
pRNFL measurements and the vertical C/D. pRNFL thickness 
values were measured for 3.46 mm diameter circles around 
the optic disc, pRNFL thickness parameters evaluated were 
average thickness and the thicknesses of four quadrant sectors 
(superior, temporal, inferior and nasal). A macular cube with 
512×128 scan mode was used for GC- IPL thickness measure-
ments, within a 6 mm diameter centred at the fovea. The GC- IPL 
thickness parameters evaluated were average thickness of the 
6 mm diameter region and the six quadrant sectors (superior, 
temporal- superior, temporal- inferior, inferior, nasal- inferior and 
nasal- superior).
Angiography imaging was conducted centred at the macula 
with the 6 × 6 mm scan pattern. All scans were analysed using 
Cirrus OCTA software (AngioPlex, V.10.0; Carl Zeiss Meditec). 
VD is the total length of perfused vasculature per unit area in a 
region of measurement, while PD is the total area of perfused 
vasculature per unit area in a region of measurement. VD and 
PD were performed on the annular zone after excluding the 
foveal avascular zone (FAZ). The VD, PD and FAZ area of the 
superficial capillary plexus (from the internal limiting membrane 
to the inner plexiform layer) were automatically measured by 
software from Carl Zeiss Meditec using optical microangiog-
raphy algorithms. The central foveal region was a region with a 
diameter of 1 mm, and the inner and outer rings had outer diam-
eters of 3 and 6 mm and were divided into four quadrants. The 
VD and PD values of nine quadrant sectors (central, superior- 
inner, temporal- inner, inferior- inner, nasal- inner, superior- outer, 
temporal- outer, inferior- outer and nasal- outer) and the whole 
area were analysed. Structural and microvasculature measure-
ments in representative eyes are shown in figure 1.
Although eye movement is significantly reduced by asking the 
subjects to fixate on a target during OCTA imaging, microsac-
cades could not be avoided altogether. In this study, we assume 
that we could temporarily ignore the effect of motion artefact 
in the clinical comparison of multiple diseases by using the Fast-
Trac retinal- tracking technology of high- definition OCT and 
the AngioPlex device (Cirrus 5000, V.10.0; Zeiss Meditec, Cali-
fornia, USA) and strictly applying the established standards for 
OCTA image processing. An absence of motion artefacts was 
defined as no vessel doubling, vessel discontinuity/misalignment 
or lateral vessel displacement in the OCTA image. Images with a 
signal strength <7 and those with poor centration or segmenta-
tion errors were also excluded from data analysis.
statistical analyses
All statistical analyses were performed using software (SPSS, 
V.22.0; SPSS). To adjust for age, gender and the inter- eye correla-
tion from the same participant, the generalised estimating equa-
tion (GEE) method was used throughout the analysis whenever 
applicable. Pearson’s correlation was used to assess associations 
between the OCTA parameters and correlations between OCTA 
parameters and BCVA after testing by the GEE models. Linear 
mixed- effects models were used to compare percentage losses 
of different parameters within one certain diagnostic group. 
Logistic regression was employed to combine diagnostic param-
eters into composite diagnostic indices. The area under the 
receiver operating characteristic curve (AUC) was used to calcu-
late the diagnostic power of the diagnostic parameters. An AUC 
of 1.0 represents perfect discrimination, whereas an AUC of 0.5 
represents accidental discrimination. To compare the diagnostic 
capabilities of the parameters, the AUCs were compared using 
the method described by DeLong and colleagues.20 A p<0.05 
was considered statistically significant.
resulTs
demographic data
After excluding poor- quality OCTA images, the study enrolled 
208 eyes of 124 subjects with NMOSD (113 eyes with a history 
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Figure 1 Structural and microvasculature measurements in 
representative eyes. (A, B, C) Diagram of macular and peripapillary 
measurements using optical coherence tomography angiography. pRNFL 
thickness was divided into four sectors, macular GC- IPL thickness was 
divided into six sectors and macular microvasculature was divided into 
nine sectors. OCTA images of pRNFL thickness, GC- IPL thickness and 
macular microvasculature: (i) in an eye from a patient with NMOSD (D, 
E, F); (ii) in an eye from a patient with POAG (G, H, I); and (iii) in an eye 
from a healthy control (J, K, L). Macular microvasculature was measured 
in the superficial capillary plexus. C, central; GC- IPL, ganglion cell- 
inner plexiform layer; I, inferior; I- I, inferior- inner; I- O, inferior- outer; N, 
nasal; NI, nasal- inferior; N- I, nasal- inner; NMOSD, neuromyelitis optica 
spectrum disorder; N- O: nasal- outer; NS, nasal- superior; POAG, primary 
open angle glaucoma; pRNFL, peripapillary retinal nerve fibre layer; S, 
superior; S- I superior- inner; S- O, superior- outer; T, temporal; TI, temporal- 
inferior; T- I, temporal- inner; T- O, temporal- outer; TS, temporal- superior.
Table 1 Demographic data and clinical characteristics of patients
Parameter nMo PoAG healthy controls P value
Patients (n) 124 NMO- ON: 62 102 G- E: 59 62 –
NMO+ON: 62 G- A: 43
Eyes (n) 208 NMO- ON: 95 124 G- E: 74 90 –
NMO+ON: 113 G- A: 50
Age, median, (IQR), years* 37 (29.5–48) 43 (35–53.5) 40.5 (29–55) <0.0001
Sex, female:male† 110:14 33:69 36:27 <0.0001
Percentage of patients with AQP4- IgG+ 94.4% – – –
BCVA, mean (SD) 0.57 (0.37) 0.86 (0.22) 1.02 (0.13) <0.0001
*Kruskal- Wallis test, p<0.05 was considered to be statistically significant.
†χ2 test, p<0.05 was considered to be statistically significant.
BCVA, best- corrected visual acuity.
of ON, 95 eyes without a history of ON), 124 eyes of 102 
subjects with POAG (74 eyes with G- E, 50 eyes with G- A) and 
90 eyes of 62 healthy controls. The demographics of the anal-
ysed eyes are shown in table 1.
Patterns of losses in macular GC-IPl and microvasculature
The structural and microvascular parameters were first 
compared between NMOSD and POAG eyes, using GEE models 
to adjust for age, gender and within- subject inter- eye correla-
tions (table 2). The two groups had similar pRNFL thick-
nesses (NMOSD: 82.28±19.89 µm, POAG: 74.54±16.58 µm, 
p=0.126). The NMOSD group showed significant thinning of 
GC- IPL at the nasal- superior quadrant (p=0.007), whereas the 
POAG group had a significantly reduced GC- IPL at the inferior 
and temporal- inferior quadrants (p=0.016, p<0.0001, respec-
tively). In addition, the NMOSD group showed significantly 
reduced macular VD and PD compared with the POAG group in 
all nine quadrants (figure 2A).
As the pRNFL average thickness was also comparable 
(p=0.138) between NMO+ON (68.99±14.27 µm) and G- A 
(62.40±11.23 µm), we next compared the macular GC- IPL and 
microvasculature in these two groups (table 2). The thickness of 
the GC- IPL was significantly reduced in the superior, superior- 
nasal and inferior- nasal quadrants in NMO+ON (p=0.039, 
p=0.001, p=0.007, respectively), and reduced in the temporal- 
inferior quadrant in G- A (p<0.0001), showing significant differ-
ences for the quadrant distribution between NMO+ON and G- A 
eyes (figure 2B). The macular VD and PD in all nine quadrants 
were significantly lower in NMO+ON than in G- A.
To show detailed patterns of losses in each subgroup, the 
macular GC- IPL, microvascular parameters and pRNFL of NMO- 
ON, NMO+ON, G- E and G- A were compared with the healthy 
control group (figure 2C–F, online supplementary table S1). 
The order of percentage losses in average GC- IPL thickness was 
NMO+ON>G- A>G- E>NMO- ON. The order of percentage 
losses in whole macular VD and PD was NMO+ON>NMO- 
ON>G- A>G- E. The percentage loss was calculated as(1 − (raw 
measurement/mean value of healthy eyes))×100(%).
Correlation analysis between structural and angiography 
parameters
In each subgroup, VD was strongly correlated with PD (healthy 
controls: r=0.994, p<0.0001; G- E: r=0.961, p<0.0001; 
G- A: r=0.975, p<0.0001; NMO- ON: r=0.975, p<0.0001; 
NMO+ON: r=0.996, p<0.0001), so we used VD as a repre-
sentative microvasculature manifestation in the following anal-
ysis. Correlation analysis showed that the average thicknesses of 
GC- IPL were significantly and positively correlated with macular 
whole VDs in both NMOSD (r=0.294, p<0.0001) and POAG 
(r=0.540, p<0.0001), as well as in each subgroup (NMO- ON: 
r=0.224, p=0.046; NMO+ON: r=0.217, p=0.028; G- E: 
r=0.490, p=0.001; G- A: r=0.298, p=0.016).
Correlation analysis between oCTA values and visual function
In both disease groups, the BCVA and mean deviation of visual 
field were significantly correlated with all pRNFL parameters. 
Among all RNFL parameters, the average pRNFL thickness in 
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Table 2 Comparison of optical coherence tomography angiography measures after adjusting for age, gender and inter- eye correlation
oCTA parameters
nMosd vs PoAG nMo+on vs G- A
nMosd value (sd) PoAG value (sd) nMo+on value (sd) G- A value (sd)
Average prnFl 82.28 (19.89) 74.54 (16.58) 68.99 (14.27) 62.40 (11.23)
S pRNFL 100.14 (28.82) 93.41 (28.88) 83.40 (24.21) 74.26 (23.60)
T pRNFL 60.64 (20.26) 61.28 (15.33) 49.23 (13.43) 51.90 (10.67)
I pRNFL 106.31 (32.87)*** 78.71 (22.11) 85.93 (26.20)*** 63.42 (11.33)
N pRNFL 62.28 (11.90)* 64.93 (11.24) 57.78 (10.30) 60.00 (9.36)
Average GC- IPl 70.26 (14.07) 68.26 (11.12) 60.79 (10.54) 61.18 (8.39)
S GC- IPL 70.80 (14.40) 71.52 (13.20) 61.49 (11.43)* 64.02 (11.33)
TS GC- IPL 70.26 (13.27) 68.34 (13.06) 62.11 (11.37) 60.28 (10.44)
TI GC- IPL 71.35 (13.26)*** 60.94 (9.72) 63.10 (10.96)*** 54.78 (5.37)
I GC- IPL 69.47 (13.48)* 63.82 (9.87) 60.64 (10.13) 57.84 (6.89)
NI GC- IPL 69.41 (16.05) 70.90 (12.80) 58.35 (11.03)** 63.6 (11.05)
NS GC- IPL 70.92 (16.21)** 74.64 (14.00) 59.95 (11.89)** 67.56 (13.50)
Whole Vd 14.47 (3.45)*** 16.83 (1.51) 13.66 (3.46)*** 16.19 (1.57)
Central Vd 5.79 (3.33)*** 8.48 (2.91) 5.08 (2.84)*** 8.51 (3.10)
Whole Pd 0.3504 (0.0870)*** 0.4149 (0.0384) 0.3295 (0.0887)*** 0.3996 (0.0397)
Central Pd 0.1262 (0.0768)*** 0.1885 (0.0666) 0.1094 (0.0647)*** 0.1893 (0.0704)
FAZ area 0.2473 (0.1210)*** 0.2956 (0.1282) 0.2496 (0.1257)*** 0.2718 (0.1090)
OCTA values are presented as mean (SD). VD, PD and FAZ were measured in the superficial capillary plexus. pRNFL and GC- IPL thicknesses are expressed in μm, VD and PD in mm-1, FAZ area in mm2.
*p<0.05; **p<0.01; ***p<0.001.
GC- IPL, ganglion cell- inner plexiform layer; FAZ, foveal avascular zone; G- A, advanced glaucoma; I, inferior; N, nasal; NI, nasal- inferior; NMOSD, neuromyelitis optica spectrum disorder; NS, nasal- superior; OCTA, 
optical coherence tomography angiography; ON, optic neuritis; PD, perfusion density; POAG, primary open- angle glaucoma; pRNFL, peripapillary retinal nerve fibre layer; S, superior; T, temporal; TI, temporal- inferior; TS, 
temporal- superior; VD, vessel density.
Figure 2 Comparison of structural and angiography parameters 
between groups. (A) Topographic damage in NMOSD compared with 
POAG with similar pRNFL average thicknesses. The thickness of the 
GC- IPL was significantly reduced in the nasal- superior quadrant in 
NMOSD, and reduced in the inferior and temporal- inferior quadrants 
in POAG. The NMOSD group showed significantly reduced macular VD 
compared with the POAG group in all nine quadrants. (B) Topographic 
damages of NMO+ON compared with G- A with similar pRNFL average 
thicknesses. The thickness of the GC- IPL was significantly reduced in the 
superior, superior- nasal and inferior- nasal quadrants in NMO+ON, and 
reduced in the temporal- inferior quadrant in G- A. The NMO+ON group 
showed significantly reduced macular VD compared with G- A in all nine 
quadrants. (C–F) Topographic damages of NMO- ON, NMO+ON, G- E 
and G- A compared with healthy controls. GC- IPL, ganglion cell- inner 
plexiform layer; NMOSD, neuromyelitis optica spectrum disorder; POAG, 
primary open angle glaucoma; pRNFL, peripapillary retinal nerve fibre 
layer; VD, vessel density.
the NMOSD and POAG groups (r=0.558, p<0.0001; r=0.419, 
p<0.0001, respectively) showed the highest correlation with 
BCVA. There were also significant correlations between the 
BCVA and all GC- IPL parameters, as well as between the mean 
deviation of the visual field and overall GC- IPL parameters. 
Among all GC- IPL parameters, the average GC- IPL thickness in 
the NMOSD and POAG groups (r=0.530, p<0.0001; r=0.506, 
p<0.0001, respectively) showed the highest correlation with 
BCVA .
For macular VD and PD, we observed significant positive 
correlations between the BCVA and central, inner and outer 
segments, and the whole area in both NMOSD and POAG. In 
NMOSD, there were significant correlations between BCVA and 
vascular parameters in the central, inferior- inner, inferior- outer, 
superior- outer and nasal- outer segments. No statistically signif-
icant correlations were found between FAZ area and BCVA or 
FAZ area and mean deviation of visual field in both NMOSD 
and POAG.
Comparison of percentage losses in macular GC-IPl and Vd
The percentage losses in GC- IPL thickness and VD in each 
subgroup were compared (online supplementary figure S1). 
Based on a multivariate analysis, after adjustment for age and 
sex, the percentage loss in average GC- IPL thickness was signifi-
cantly more severe than in whole macular VD in the G- E (GC- 
IPL: 9.22%±8.26%, VD: 3.47%±5.36%, p<0.0001) and 
G- A groups (GC- IPL: 27.96%±9.88%, VD: 11.32%±8.59%, 
p<0.0001), while whole macula VD was significantly more 
severe in the NMO- ON group (GC- IPL: 5.19%±11.19%, 
VD: 15.92%±16.76%, p<0.0001). The percentage losses in 
GC- IPL and VD were similar in the NMO+ON group (GC- IPL: 
28.43%±11.41%, VD: 25.20%±16.94%, p=0.13).
diagnostic accuracy of oCTA parameters
The diagnostic capabilities of the OCTA parameters calculated 
by AUCs are presented in figure 3 and online supplementary 
table S2. GEE models were used to adjust for age, gender and 
inter- eye correlation.
To discriminate NMOSD from POAG and healthy controls 
or to discriminate POAG from NMOSD and healthy controls 
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Figure 3 Diagnostic accuracies of optical coherence tomography 
angiography (OCTA) parameters in discriminating among patients with 
neuromyelitis optica spectrum disorder (NMOSD), patients with primary 
open angle glaucoma (POAG) and healthy controls. (A) Distinguishing 
NMOSD from POAG and healthy controls. In the specific structural 
optical coherence tomography (OCT) parameters, temporal peripapillary 
retinal nerve fibre layer (pRNFL) and nasal ganglion cell- inner plexiform 
layer (GC- IPL) were selected for NMOSD. (B) Distinguishing POAG from 
NMOSD and healthy controls. In the specific structural OCT parameters, 
inferior pRNFL and nasal GC- IPL were selected for POAG. (C) 
Distinguishing NMO- ON from NMO+ON, G- E, G- A and healthy controls. 
In the specific structural OCT parameters, inferior pRNFL and nasal GC- 
IPL were selected for the NMO- ON group. (D) Distinguishing G- E from 
NMO- ON, NMO+ON, G- A and healthy controls. In the specific structural 
OCT parameters, superior pRNFL and inferior GC- IPL were selected for 
the G- E group. (E) Distinguishing NMO+ON from NMO- ON, G- E, G- A 
and healthy controls. In the specific structural OCT parameters, temporal 
pRNFL and nasal GC- IPL were selected for the NMO+ON group. (F) 
Distinguishing G- A from NMO- ON, NMO+ON, G- E and healthy controls. 
In the specific structural OCT parameters, inferior pRNFL and temporal 
GC- IPL were selected for the G- A group.
(online supplementary table S2a), the structural OCT parame-
ters (pRNFL average thickness, vertical C/D and GC- IPL average 
thickness) combined with the VD significantly improved diag-
nostic accuracies compared with only the structural parameters 
(NMOSD: p=0.0003, POAG: p=0.0354). After selecting the 
specific quadrants of GC- IPL and pRNFL with the best perfor-
mance to replace the average thicknesses (temporal pRNFL and 
nasal GC- IPL were selected for NMOSD; inferior pRNFL and 
nasal GC- IPL were selected for POAG), the adjusted structural 
OCT parameters combining the VD and FAZ showed even 
better diagnostic capability (NMOSD: p=0.0054, AUC range 
0.917~0.966; POAG: p=0.0498, AUC range 0.943~0.989).
For the detection of subgroups (online supplementary table 
S2b), we quantified the diagnostic capabilities of the OCTA 
parameters to discriminate one single subgroup from the others. 
The specific structural OCT parameters modified with quad-
rant information combining VD and FAZ also showed the best 
diagnostic capability for the discrimination of all subgroups 
(NMO+ON: AUC range 0.913~0.963; NMO- ON: AUC range 
0.828~0.899; G- A: AUC range 0.961~0.992; G- E: AUC range 
0.852~0.918). Among the macular VD parameters, no specific 
quadrant of VD or PD showed better diagnostic capability than 
the whole macula VD to discriminate between groups.
FAZ in oCTA as a new biomarker for nMosd and PoAG
The FAZ area was found to be associated with diagnostic 
accuracy in patients with POAG (online supplementary table 
S2a). The FAZ area of eyes with NMOSD, with and without a 
history of ON (NMO+ON: 0.2496±0.1257 mm2, NMO- ON: 
0.2448±0.1163 mm2), was significantly smaller than that in 
healthy controls (0.2858±0.1064 mm2) and POAG eyes (G- A: 
0.2718±0.1090 mm2, G- E: 0.3252±0.1448 mm2). Comparing 
the binocular FAZ indices of NMOSD patients who experienced 
monocular ON (n=28), the FAZ area of the eyes with a history 
of ON (NMO+ON: 0.2450±0.12039 mm2) was smaller than in 
the contralateral eyes (NMO- ON: 0.2546±0.12279 mm2), but 
this difference was not statistically significant (p=0.352).
The size of the FAZ area was found to have a significant nega-
tive correlation with central VD in healthy controls (r=−0.690, 
p<0.0001), G- A (r=−0.505, p<0.0001), G- E (r=−0.485, 
p=0.002) and NMO- ON (r=−0.227, p=0.027). In the 
NMO+ON group, FAZ area measurement was not correlated 
with central VD or central PD (r=−0.029, p=0.771; r=−0.021, 
p=0.833, respectively). We did not find any correlation between 
the FAZ size and the other parameters, including vertical C/D.
dIsCussIon
NMOSD and POAG are two important causes of registrable 
blindness worldwide.8 21 There is an accumulating body of 
evidence that the damage seen in the brain and the retina may 
be driven by common mechanisms in these two diseases. In glau-
coma, the responses triggered by axonal injury are likely to be 
rapidly transmitted both to the retinal ganglion cell body within 
the inner retina and more distally to the brain, affecting the 
lateral geniculate nucleus and the visual cortex.8 In NMOSD, 
retrograde transynaptic degeneration has been demonstrated 
in vivo, implying that abnormalities occurring within the brain 
could be reflected in the retina, and therefore quantifiable with 
high- resolution OCT imaging modalities.22–24 Numerous studies 
have shown that both NMOSD and POAG typically result in 
GC- IPL and pRNFL thinning, indicating the death of a substan-
tial number of retinal ganglion cells and loss of their axons in 
the optic nerve.5–9 In addition, superficial microvascular dropout 
has been observed in patients with NMOSD and POAG.4 11 25 
Patients with NMOSD and early glaucoma have been inves-
tigated separately using OCTA, and both show significantly 
decreased macular GC- IPL and VD compared with healthy 
controls.4 11 To the best of our knowledge, however, this is the 
first study to assess and compare the patterns of structural and 
microvascular damage seen in eyes with NMOSD and POAG.
We found that the patterns and severity of macular GC- IPL 
and microvascular loss differed significantly between NMOSD 
and POAG. GC- IPL thinning was more severe in the superior 
and nasal quadrants in NMOSD and in the inferior and temporal 
quadrants in POAG. Patients with NMOSD had a significantly 
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lower VD and PD in all quadrants and a decreased size of the 
FAZ area in comparison with POAG. In addition, we observed 
that the extent of GC- IPL thinning was more severe than the 
VD reduction in POAG eyes (both G- E and G- A), while the 
extent of GC- IPL thinning was less than the VD reduction in 
the NMOSD group. Our data confirmed the discrimination 
capability of OCTA by quantifying specific loss patterns in the 
macular ganglion cells and microvasculature, with the best AUCs 
above 0.94 for each disease, and above 0.86 for each subgroup. 
The results of our study further demonstrate that NMOSD and 
POAG share overlapping vascular changes,26–28 although the 
degree and patterns of changes observed will reflect the different 
pathophysiology that underlie these two optic neuropathies.
In POAG eyes, the percentage loss in the pRNFL was the 
greatest, indicating that this area is a prominent injury site. Losses 
in the macular GC- IPL caused by apoptosis of retinal ganglion 
cells were then triggered by axon injury, which was rapidly trans-
mitted from the optic disc to the retinal ganglion cell body.8 We 
assumed that the macular microvasculature, which is less sensi-
tive to disease progression than the axons, may reflect secondary 
retinal degeneration in POAG. The loss of retinal ganglion cells 
and their axons occurs selectively, with the worst damage in the 
inferior and temporal quadrants, and the macular microvascular 
damages start from the inferior- outer and temporal- outer quad-
rants, which are both coincident with the structural map of the 
axons and the visual field defects.8 In NMOSD eyes, a severe 
reduction in the macular GC- IPL and microvasculature may be 
correlated with AQP4- IgG+, given that the fovea is enriched in 
AQP4- expressing Müller cells, which encompass ganglion cells, 
contributing to the tight junctions of the blood–brain barrier and 
playing an important part in the control of osmotic and ionic 
homeostasis.29–32 The ongoing loss of AQP4 results in Müller 
cell swelling under hypotonic conditions and induces an inflam-
matory response in the retinal tissues of NMOSD eyes,33 during 
which the macular ganglion cells and microvasculature could 
be greatly impaired. Subclinical primary retinal pathology in 
macular foveal thickness, prior to pRNFL thinning, in NMO- ON 
patients has been demonstrated in a previous study.3 However, 
the exact mechanisms of neuroinflammation, axonal loss and 
demyelination in NMOSD remain unknown.32 We speculate that 
these pathological changes in the macula including GP- IPL struc-
ture and microvasculature indicate primary sites of injury, while 
thinning of the pRNFL represents secondary retinal degener-
ation in NMOSD. The pathophysiology of the distinct distri-
bution of GC- IPL thinning in the nasal and superior quadrants 
deserves further evaluation. The nasal preponderance of GC- IPL 
damage in NMOSD might be related to a greater sensitivity to 
injury in the papillomacular bundle, which has been observed 
in patients with multiple sclerosis presenting with ON.34 35 As 
expected, there was a significant correlation between BCVA and 
both pRNFL and GC- IPL parameters in the NMOSD and POAG 
disease groups.
The FAZ, which is a small region devoid of retinal vessels in 
the centre of the fovea, has been quantified in other neurodegen-
erative diseases, such as Alzheimer disease and Parkinson disease 
to determine its relevance to the pathology and disease progres-
sion.36 37 Patients with Alzheimer disease (n=27 eyes) had the 
largest mean FAZ area, which was significantly different from 
that of POAG (n=27 eyes) (p<0.001) as well as healthy controls 
(n=27 eyes) (p<0.001).36 In contrast, the FAZ area in Parkinson 
disease (n=25 eyes) was significantly smaller compared with 
healthy controls (n=17 eyes) (p=0.02).37 Our findings provide 
new information regarding the FAZ measurements in eyes with 
NMOSD (n=208 eyes). The FAZ size was significantly reduced 
in eyes with NMOSD compared with both healthy controls 
(n=90 eyes) and POAG eyes (n=124 eyes). Moreover, the 
percentage loss in the FAZ was comparable with that in the 
GC- IPL and it was significantly greater than the pRNFL in eyes 
with NMO- ON. This finding suggests that FAZ may be a novel 
and sensitive biomarker of retinal neuron loss in NMOSD. The 
reasons for the lengthening of foveal capillaries and the smaller 
FAZ area in NMOSD remain to be clarified. Although the 
AQP4- expressing Müller cells in FAZ may play an aetiological 
role in vascular remodelling in NMOSD, additional studies are 
required to quantify capillary remodelling and to demonstrate 
whether cell loss or damage leads to vasculogenesis from the 
surrounding capillaries. Our findings need independent repli-
cation and further studies with repeated measurements over a 
longer follow- up period will provide more detailed information 
about the chronology and changes in FAZ metrics in NMOSD. 
In addition, reliable OCTA is only possible in regions where 
there is a strong signal. Therefore, OCTA cannot detect flow in 
low signal regions even if it is present. As blood flow in ocular 
vessels of NMOSD is slow, the vessels may be silent on OCTA, 
creating a false- negative appearance even if they are present.
In summary, this is the first study comparing macular GC- IPL 
and microvasculature between patients with NMOSD compared 
with POAG and healthy controls. The results showed that 
NMOSD and POAG are associated with specific patterns of 
retinal structural and microvasculature dysfunction reflecting 
their different pathogenesis. FAZ area in NMOSD represents an 
attractive disease biomarker that could be applied to monitoring 
disease progression and as an outcome measure in clinical trials 
investigating novel immunomodulatory agents.
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